Lambert-Eaton Myasthenic Syndrome Caused by Nivolumab in a Patient with Squamous Cell Lung Cancer

Lambert-Eaton myasthenic syndrome (LEMS) is a representative paraneoplastic neurological syndrome. Recently, nivolumab, an anti-programmed cell death 1 inhibitor, has been approved for advanced non-small-cell lung cancer. Careful attention should be paid to immune-related adverse events (irAEs), inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakatani, Yuki, Tanaka, Natsuki, Enami, Tomomi, Minami, Seigo, Okazaki, Tomoko, Komuta, Kiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323386/
https://www.ncbi.nlm.nih.gov/pubmed/30627102
http://dx.doi.org/10.1159/000494078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323386/
https://www.ncbi.nlm.nih.gov/pubmed/30627102
http://dx.doi.org/10.1159/000494078

Ejemplares similares